Biopharma | June 08, 2026
Biocon Academy graduates 156 students at 10th convocation
The graduating cohort comprised seven batches across five specialized programs
The graduating cohort comprised seven batches across five specialized programs
Investigational once-weekly GLP-1 and amylin receptor agonist achieves up to 14.6% weight loss and significant blood sugar reductions
The agreement underscores Roche’s commitment to advancing innovative therapies for blood cancers and other serious diseases
Amitabh Dube and Sheetal Arora named Co-Chairmen for the forthcoming term
The webinar on World Environment Day brought together scientists, policymakers, industry representatives, and researchers to discuss the role of biotech and biomanufacturing in addressing climate change and advancing sustainable development
The addition of the Halcyon system represents a significant milestone in the hospital’s oncology services
Ranluspec is the only interchangeable ranibizumab biosimilar approved in the United States in both vial and pre-filled syringe (PFS) presentations
Rahul brings over 17 years of experience in human resources leadership across the healthcare, banking, information technology, and FMCG sectors
Multi-target licensing agreement combines Stipple Bio’s epitope discovery platform with Lonza’s ADC technologies to develop targeted cancer treatments
Seasoned pharma leader recognized for driving sales excellence, marketing strategy, and business growth
Subscribe To Our Newsletter & Stay Updated
